MD vs. V

Last updated Aug 4, 2026

MD (MEDNAX, Inc.) and V (Visa Inc.) are both stocks. MD operates in Medical Care Facilities (Healthcare), while V operates in Credit Services (Financial Services). Over the past 10 years, MD returned -8.86%/yr vs 17.22%/yr for V. Their 0.29 correlation means their historical movements had little consistent relationship.

Performance

MD vs. V - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in MEDNAX, Inc. (MD) and Visa Inc. (V). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, MD achieves a 22.72% return, which is significantly higher than V's 4.70% return. Over the past 10 years, MD has underperformed V with an annualized return of -8.86%, while V has yielded a comparatively higher 17.22% annualized return.

MD

• 1D: -0.98%
• 1M: -1.91%
• 6M: 22.43%
• YTD: 22.72%
• 1Y: 119.12%
• 3Y*: 21.51%
• 5Y*: -2.44%
• 10Y*: -8.86%
• ALL TIME*: 5.27%

V

• 1D: -0.13%
• 1M: 0.98%
• 6M: 9.99%
• YTD: 4.70%
• 1Y: 8.61%
• 3Y*: 16.11%
• 5Y*: 9.91%
• 10Y*: 17.22%
• ALL TIME*: 19.89%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison

Position	Avg. Volume Value (2W)	Avg. Volume Value (1M)	Avg. Volume Value (3M)
MD MEDNAX, Inc.	$16.19M	$19.25M	$19.49M
V Visa Inc.	$2.54B	$2.73B	$2.81B

MD vs. V - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
MD MEDNAX, Inc.	22.72%	63.03%	41.08%	-37.42%	-45.39%	10.88%	-11.69%	-15.79%	-38.25%	-19.83%
V Visa Inc.	4.70%	11.76%	22.32%	26.31%	-3.40%	-0.31%	17.12%	43.33%	16.49%	47.18%

Correlation

The correlation between MD and V is 0.21, which is low. Their historical price movements had little consistent relationship.

	Correlation
Correlation (1Y) Focuses on recent behavior, but can change the most.	0.21
Correlation (3Y) Balances recent behavior with more history.	0.25
Correlation (5Y) Shows whether the relationship held over a longer period.	0.29
Correlation (10Y) Provides a long-term view across more market conditions.	0.25
Correlation (All Time) Calculated using the full available price history since Mar 19, 2008	0.29

Fundamentals

Market Cap MD : $2.16B V : $682.72B
EPS MD : $2.07 V : $15.55
PE Ratio MD : 12.71 V : 23.51
PEG Ratio MD : 1.54 V : 1.44
PS Ratio MD : 1.15 V : 11.94
Total Revenue (TTM) MD : $1.93B V : $44.49B
Gross Profit (TTM) MD : $385.43M V : $8.74B
EBITDA (TTM) MD : $243.92M V : $27.77B

Return for Risk

MD vs. V — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

MD

MD Risk / Return Rank: 95
MD Sharpe Ratio Rank: 96
MD Sortino Ratio Rank: 95
MD Omega Ratio Rank: 95
MD Calmar Ratio Rank: 95
MD Martin Ratio Rank: 93

V

V Risk / Return Rank: 55
V Sharpe Ratio Rank: 59
V Sortino Ratio Rank: 52
V Omega Ratio Rank: 51
V Calmar Ratio Rank: 57
V Martin Ratio Rank: 58

The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

MD vs. V - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for MEDNAX, Inc. (MD) and Visa Inc. (V). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	MD	V	Difference
Sharpe ratio: Return per unit of total volatility	2.70	0.39	+2.30
Sortino ratio: Return per unit of downside risk	3.57	0.75	+2.82
Omega ratio: Gain probability vs. loss probability	1.49	1.09	+0.40
Calmar ratio: Return relative to maximum drawdown	5.07	0.50	+4.56
Martin ratio: Return relative to average drawdown	12.15	1.12	+11.03

MD vs. V - Sharpe Ratio Comparison

The current MD Sharpe Ratio is 2.70, which is higher than the V Sharpe Ratio of 0.39. The chart below compares the historical Sharpe Ratios of MD and V, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

MD vs. V - Drawdown Comparison

The maximum MD drawdown since its inception was -92.08%, which is greater than V's maximum drawdown of -51.90%. Use the drawdown chart below to compare losses from any high point for MD and V.

Drawdown Indicators

	MD	V	Difference
Max Drawdown Largest peak-to-trough decline	-92.08%	-51.90%	-40.18%
Max Drawdown (1Y) Largest decline over 1 year	-23.65%	-17.18%	-6.47%
Max Drawdown (3Y) Largest decline over 3 years	-54.69%	-20.38%	-34.31%
Max Drawdown (5Y) Largest decline over 5 years	-80.74%	-25.79%	-54.95%
Max Drawdown (10Y) Largest decline over 10 years	-90.60%	-36.36%	-54.24%
Current Drawdown Current decline from peak	-69.29%	-1.27%	-68.02%
Average Drawdown Average peak-to-trough decline	-38.90%	-8.24%	-30.66%
Ulcer Index Depth and duration of drawdowns from previous peaks	9.84%	7.73%	+2.11%

Volatility

MD vs. V - Volatility Comparison

MEDNAX, Inc. (MD) has a higher volatility of 12.93% compared to Visa Inc. (V) at 5.88%. This indicates that MD's price experiences larger fluctuations and is considered to be riskier than V based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	MD	V	Difference
Volatility (1M) Calculated over the trailing 1-month period	12.93%	5.88%	+7.05%
Volatility (6M) Calculated over the trailing 6-month period	28.00%	16.91%	+11.09%
Volatility (1Y) Calculated over the trailing 1-year period	44.48%	21.96%	+22.52%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	44.39%	22.90%	+21.49%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	46.09%	24.45%	+21.64%

Dividends

MD vs. V - Dividend Comparison

MD has not paid dividends to shareholders, while V's dividend yield for the trailing twelve months is around 0.71%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
MD MEDNAX, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
V Visa Inc.	0.71%	0.70%	0.68%	0.72%	0.76%	0.62%	0.56%	0.56%	0.67%	0.61%	0.75%	0.64%

Financials

Frequently Asked Questions

Can I hold both MD and V in my portfolio?

MD and V have a correlation of 0.21, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, MD or V?

MD has higher volatility (12.93%) compared to V (5.88%). In terms of maximum drawdown, MD dropped -92.08% vs V's -51.90%.

Which has better risk-adjusted returns?

MD currently has the higher Sharpe Ratio (2.70 vs 0.39), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.